EU project improves quality of life for patients with chronic lung disease

Researchers from an EU funded project have developed a care system for patients with Chronic Obstructive Pulmonary Disease (COPD) which promises to reduce hospital admissions and improve patients' quality of life.

COPD is a progressive lung disease whose symptoms include shortness of breath, coughing, wheezing and recurrent respiratory infections. As the disease progresses, many patients suffer 'exacerbations', which typically involve a sudden worsening of the symptoms and, in the most severe cases, can lead to respiratory failure. Exacerbations are treated with bronchodilators, antibiotics and steroids.

Hospital admissions due to exacerbations represent a major problem for healthcare systems, as they generally worsen the patients' quality of life and place a significant economic burden on hospitals.

Researchers in Barcelona, Spain and Leuven, Belgium designed an alternative, integrated care system aimed at reducing levels of hospitalisation among COPD patients. They then assigned patients who had been hospitalised due to COPD at random to either the usual follow-up system or the new integrated care system.

Under the integrated care system, on discharge from the hospital a comprehensive assessment of the patient looked at the severity of the patient's COPD, other health problems and social support needs. A two hour course on COPD provided patients with information on the disease in general, tips on how to better manage their symptoms and strategies for coping with future exacerbations. Following that, an individually tailored care plan was designed and distributed to all involved in the patient's treatment. Finally, both patients and carers were provided with access to a specialised nurse through a web-based call centre which was designed by the EU-funded CHRONIC project. Regular follow-up phone calls served to remind patients of the self-management strategies.

Patients in the usual care system were discharged from hospital and followed up by their doctor as normal, without the extra support offered to the integrated care patients. All patients in the study were followed for one year.

The researchers found that patients in the integrated care group were less likely to be re-hospitalised than those in the usual care group. The researchers attribute the success of the integrated care group to an enhanced self-management of the disease, higher levels of access to healthcare professionals, and greater levels of cooperation between health care professionals from a range of sectors. Their results are published in the European Respiratory Journal.

A total of 60 per cent of patients admitted in emergencies have a chronic pathology. Treating these patients at the appropriate level can reduce pressures on hospitals and improve patients' quality of life, said the researchers.

For further information, please visit:
www.idibaps.ub.edu/eng/home.php

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...